# GERCOR

Source: https://onco.cc/companies/gercor/  
OnCo record `gercor` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

GERCOR is a French non-profit cooperative group created in 1997 that sponsors its own phase 2 and 3 solid tumour trials through a network of about 300 investigators; in OnCo it leads LAP07 in locally advanced pancreatic cancer.

## Summary

GERCOR was created in 1997 as a non-profit entity whose mission is to improve treatment for patients with solid tumours through innovative multidisciplinary clinical research; it sponsors phase 2 and phase 3 trials independently and draws on a national network of 300 members in about a hundred centres, from an office at 151 rue du Faubourg Saint-Antoine, Paris (gercor.com). ClinicalTrials.gov registers it as GERCOR - Multidisciplinary Oncology Cooperative Group (OTHER class) and names it lead sponsor of LAP07 (NCT00634725, phase 3, chemoradiotherapy against chemotherapy alone after induction in locally advanced pancreatic cancer), the trial recorded in OnCo. It has no products of its own.

## Fields

- Kind: Company
- Last checked: 2026-09-25
- Also known as: GERCOR - Multidisciplinary Oncology Cooperative Group; Groupe Coopérateur Multidisciplinaire en Oncologie
- Tags: ctgov-sponsor; cooperative-group
- HQ: Paris
- Type: cooperative-group
- Website: https://www.gercor.com

## Sources

- Official website: https://www.gercor.com
- ClinicalTrials.gov: trials led by GERCOR - Multidisciplinary Oncology Cooperative Group: https://clinicaltrials.gov/search?lead=GERCOR%20-%20Multidisciplinary%20Oncology%20Cooperative%20Group

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- trials: [LAP07](https://onco.cc/trials/lap07/)

---
JSON: https://onco.cc/api/v1/entities/gercor.json